All News #Library
Biotech
Crescendo announces first U.S. patients dosed in Phase 1b trial of CB307
06 Dec 2023 //
GLOBENEWSWIRE
Crescendo Biologics Secures $32M to Expand CB307 Trial
25 Jul 2023 //
CONTRACT PHARMA
Crescendo secures $32M and announces expansion of CB307 Ph 1b trial
24 Jul 2023 //
BUSINESSWIRE
Angle PLC, Crescendo Biologics Ink Clinical Services Contract
13 Apr 2023 //
CONTRACT PHARMA
Angle PLC Announces Pharma Services Contract with Crescendo Biologics
13 Apr 2023 //
ACCESSWIRE

Market Place
Sourcing Support